Magnetic helmet trial aims to slow deadly brain tumors
NCT ID NCT06533163
First seen Jun 05, 2026 · Last updated Jun 19, 2026 · Updated 2 times
Summary
This pilot trial tests a portable, wearable device that delivers low-intensity magnetic therapy to people with newly diagnosed glioblastoma, an aggressive brain cancer. The study will enroll 30 adults who have had surgery and are able to receive standard radiotherapy. The main goal is to check the device's safety, but researchers will also monitor tumor response on MRI scans and progression-free survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Center Lünen
RECRUITINGLünen, North Rhine-Westphalia, 44534, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinical Center Stuttgart
RECRUITINGStuttgart, Baden-Wurttemberg, 70174, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical Center Mannheim
RECRUITINGMannheim, 68167, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Technical University of Munich
RECRUITINGMünchen, Bavaria, 81675, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Bonn
RECRUITINGBonn, North Rhine-Westphalia, 53127, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Leipzig
RECRUITINGLeipzig, Saxony, 04103, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Oncomagnetic device (wearable magnetic therapy device)
What this could lead to
If it works, this could point toward a noninvasive way to slow glioblastoma growth alongside standard care.
What could go wrong
This is a very early pilot trial with only 30 people, focused on safety. It may not show any benefit, and the device is not a proven treatment.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.